Response to Re: Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

J Hepatobiliary Pancreat Sci. 2018 Jun;25(6):E6. doi: 10.1002/jhbp.560.

Authors

Harumi Gomi¹, Kohji Okamoto², Tomohiko Ukai³, Tadahiro Takada⁴

Affiliations

¹ Office of Medical Education, International University of Health and Welfare, Chiba, Japan.
² Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Fukuoka, Japan.
³ Division of Public Health, Osaka Institute of Public Health, Osaka, Japan.
⁴ Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.

PMID: 29878697
DOI: 10.1002/jhbp.560

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Cholangitis*
Cholecystitis*
Humans
Tokyo

Substances

Anti-Bacterial Agents
Anti-Infective Agents